Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Nipocalimab + SoC improves MG-ADL scores in adults with myasthenia gravis

23 Jul 2024 bởi

Adding nipocalimab to standard-of-care (SoC) treatment significantly improves Myasthenia Gravis-Activities of Daily Living (MG-ADL) scores in patients with generalized MG (gMG), according to the pivotal phase III Vivacity-MG3 study presented at EAN 2024.

Nipocalimab + SoC improves MG-ADL scores in adults with myasthenia gravis

23 Jul 2024

Product Highlight - NINLARO

23 Jul 2024

Viên nang cứng 2,3 mg, 3 mg hoặc 4 mg ixazomib

Product Highlight - NINLARO

23 Jul 2024

Product Highlight - GARDASIL®9

23 Jul 2024

Vắc-xin tái tổ hợp, hấp phụ phòng 9 týp vi-rút HPV ở người

Product Highlight - GARDASIL®9

23 Jul 2024

Bimekizumab may protect against uveitis in axial spondyloarthritis

22 Jul 2024

In the treatment of patients with axial spondyloarthritis (axSpA), the dual IL-17A/F inhibitor bimekizumab appears to lower the risk of uveitis, according to a study.

Bimekizumab may protect against uveitis in axial spondyloarthritis

22 Jul 2024

Antibiotic overtreatment prevalent in children with PPE/PE

22 Jul 2024 bởi

Children with parapneumonic effusion (PPE) or pleural empyema (PE) are often overly treated with antibiotics, particularly the frequent use of antibiotic combination therapy, reports a Germany study.

Antibiotic overtreatment prevalent in children with PPE/PE

22 Jul 2024

Over-the-counter supplement touted for improving walking distance in PAD

21 Jul 2024 bởi

Nicotinamide riboside supplements show a signal of benefit for helping patients with lower extremity peripheral arterial disease (PAD) walk more

Over-the-counter supplement touted for improving walking distance in PAD

21 Jul 2024

Acute benign myositis may occur in kids with flu infection

21 Jul 2024 bởi

Children with influenza A virus infection are susceptible to acute benign myositis (ABM), with most patients showing clinical characteristics consistent with postfebrile myalgia, reports a study.

Acute benign myositis may occur in kids with flu infection

21 Jul 2024

JAK inhibitors for autoimmune disease may confer protection against AMD

20 Jul 2024 bởi

The use of Janus kinase (JAK) inhibitors in the treatment of major autoimmune diseases appears to reduce the risk of age-related macular degeneration (AMD) for people above 40 years of age, according to a study.